Top compounds associated with response to YPEL1


Feature Type Standardized
Nominal ANOVA
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.27 4e-14
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 7e-14
mRNA BX-912 GDSC1000 pan-cancer AAC 0.24 7e-14
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 8e-14
mRNA RG-108 CTRPv2 pan-cancer AAC 0.28 1e-13
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 1e-13
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.28 1e-13
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.33 1e-13
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 2e-13
mRNA decitabine CTRPv2 pan-cancer AAC 0.21 3e-13
Download CSV